Cookie Consent by

October 27, 2020

Dr. Simón INCLIVA research group attends to the Single Cell Online Seminar


Date: November 2020 | 16:00 – 17:00 p.m. CET

Webinar series on single cell analysis. A virtual 4-part series where attendees will dive further into the technology that is giving insights into cellular heterogeneity. Despite single cell analysis already playing a major role in biological research, challenges remain to make the best use of the technologies. In this series, our expert speakers will cast a critical eye over the newest technologies, address the challenges with implementation and showcase some of the latest research.

PART I: Thursday 5th November – Webinar 1: Fuelling the Century of Biology with Single Cell and Spatial Technologies

With developments in our technical ability to separate single cells from each other and the falling cost of sequencing, single cell analysis can transform our understanding of diseases at the cellular level.

As the technology is rapidly improving, it’s difficult for anyone to stay on top of what the latest technology does, whether it is right for them or their research question. So how, and where, should you invest for the next era of single cell studies?

Join us for this interactive global panel discussion featuring world leaders in the single cell and genomics field, explore the current state of single cell studies and discover what’s on the horizon.


  • Stefania Giacomello, Researcher, SciLifeLab
  • Christophe Fleury, Science and Technology Advisor, 10x Genomics
  • Florian Baumgartner, Senior Product Manager, Visium Spatial Informatics, 10x Genomics

**PART II: *[Thursday 12th November – Webinar 2: Latest advancements in single-cell omics analysis](***

In this webinar, you’ll hear from distinguished experts in the genomics field, as they share their latest achievements applying genomic, transcriptomic and proteomic analysis at the single-cell level. You’ll dive into methodological improvements in sample preparation, biochemistry, and data analysis. In addition, we’ll help you explore several of the latest success stories targeting both fundamental questions in biology, as well as addressing clinical demands in upcoming era of precision medicine.

**Speakers:** * scRapid: faster single-cell RNA-sequencing with unparalleled sensitivity” - **Simone Picelli**, Team Leader of Single cell Genomics Platform, **Institute of Ophthalmology Basel** * “Dispensing technologies for highly efficient single-cell analysis workflows” - **Julian Riba**, Chief Scientific Officer, **Cytena** * Single-cell proteomic and transcriptomic analysis of macrophage polarization - **Nikolai Slavov**, Professor, **Northeastern University**
**PART III: *[Thursday 19th November – Webinar 3: Single cell analysis for drug discovery](***

Integrative single cell analysis provides a unique set of challenges. With single cell already playing an important role for drug discovery, learn from our speakers discussing the lessons learned from global pharma companies as they implement, refine protocols and apply the technology across the R&D pipeline.

**Speakers:** * “Pooled CRISPR screening with single cell RNA seq read-out in cancer cells” - **Antoine De Weck**, Team Lead, Oncology Data Science, **Novartis** * “Network Analysis and Human Single Cell Brain Transcriptomics Reveal Novel Aspects of Alpha-Synuclein (SNCA) Biology” - **Dinesh Kumar**, Principal Scientist, **Sanofi** * "Leveraging single-cell analysis to unravel treatment resistance mechanisms and monitor minimal residual disease" - **Kelly Kaihara**, Ph.D., Applications Manager, **MissionBio**
**PART IV: *[Thursday 26th November - Webinar details TBA](***

**Registration Link:** [](

**About the Human Uterus Cells Atlas – HUTER**
The human uterus is a flagship reproductive organ with profound implications not only in reproduction but also in women ́s health. HUTER can advance the Human Cell Atlas initiative for the exploitation potential in Obstetrics and Gynecology and biomedicine research areas such as Regenerative Medicine or Reproductive Medicine.

The uterus is itself a model for regenerative medicine since (i) endometrial tissue regenerates monthly and its transformation is executed through dynamic changes in states and interactions of multiple cell types, and (ii) myometrial tissue has remarkable regenerative capacity and extensive remodelling throughout pregnancy. Hence, the primary motivation HUTER proposal stems from the need to better understand the human uterus in order to more effectively address uterine diseases that impact women ́s health such as myomas or endometriosis and/or might contribute to infertility, infant and maternal mortality and morbidity.

HUTER technological and biological platform will be a crucial resource for the scientific and clinical communities to define the cellular basis of health and disease, allowing the rapid development of new diagnosis and prognosis tools and therapeutic advancements in the field.

Link to the project website here